Milestone Pharmaceuticals (MIST) EPS (Basic) (2018 - 2022)
Milestone Pharmaceuticals' (MIST) quarterly EPS (Basic) came in at -$0.35 in Q3 2022, down 4.9% YoY from -$0.37 in Q3 2021, and up 11.02% on a QoQ basis from -$0.4 in Q2 2022.
Milestone Pharmaceuticals (MIST) EPS (Basic) (2018 - 2022) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 5 years of EPS (Basic) data on file, last reported at -$0.35 in Q3 2022.
- Quarterly EPS (Basic) fell 4.9% year-over-year to -$0.35 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was -$0.35 (up 69.11% YoY) and the FY2021 annual result came in at -$1.02, up 39.84% from the prior year.
- EPS (Basic) grew to -$0.35 in Q3 2022, from -$0.4 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.02 in Q2 2021 to a low of -$30.44 in Q4 2018.
- A 5-year average of -$5.7 and a median of -$0.53 in 2019 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2021 — EPS (Basic) soared 103.51% — and 2022, when it tumbled 2251.35%.
- Tracing MIST's EPS (Basic) over 5 years: stood at -$30.44 in 2018, then jumped by 96.19% to -$1.16 in 2019, then soared by 74.51% to -$0.3 in 2020, then tumbled by 36.67% to -$0.4 in 2021, then advanced by 12.36% to -$0.35 in 2022.
- The last three EPS (Basic) figures came in at -$0.35 (Q3 2022), -$0.4 (Q2 2022), and -$0.4 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -0.35 |
| Jun 30, 2022 | -0.40 |
| Dec 31, 2021 | -0.40 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | 0.02 |
| Mar 31, 2021 | -0.30 |
| Dec 31, 2020 | -0.30 |
| Sep 30, 2020 | -0.40 |
| Jun 30, 2020 | -0.53 |
| Mar 31, 2020 | -0.67 |
| Dec 31, 2019 | -1.16 |
| Sep 30, 2019 | -0.52 |
| Jun 30, 2019 | -1.04 |
| Mar 31, 2019 | -17.33 |
| Dec 31, 2018 | -30.44 |
| Sep 30, 2018 | -20.16 |
| Jun 30, 2018 | -12.71 |
| Mar 31, 2018 | -15.57 |